HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roderick T Bronson Selected Research

Cre recombinase

12/2019The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
3/2010An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
8/2007A spatially and temporally restricted mouse model of soft tissue sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roderick T Bronson Research Topics

Disease

111Neoplasms (Cancer)
11/2022 - 04/2002
29Carcinogenesis
12/2021 - 10/2002
21Lung Neoplasms (Lung Cancer)
01/2022 - 06/2006
14Neoplasm Metastasis (Metastasis)
01/2018 - 11/2005
12Adenocarcinoma of Lung
01/2022 - 05/2006
11Inflammation (Inflammations)
12/2021 - 01/2006
10Breast Neoplasms (Breast Cancer)
01/2019 - 07/2007
8Atrophy
12/2020 - 06/2002
8Infections
08/2014 - 01/2006
7Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2010
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2005
7Sarcoma (Soft Tissue Sarcoma)
01/2018 - 07/2003
6Glioblastoma (Glioblastoma Multiforme)
01/2020 - 09/2010
6Melanoma (Melanoma, Malignant)
01/2020 - 03/2006
6Hepatocellular Carcinoma (Hepatoma)
01/2018 - 07/2010
5Adenocarcinoma
01/2022 - 04/2003
5Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 11/2011
5Carcinoma (Carcinomatosis)
10/2018 - 07/2003
5Prostatic Neoplasms (Prostate Cancer)
01/2015 - 11/2005
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 05/2006
4Sepsis (Septicemia)
01/2020 - 08/2014
4Diarrhea
01/2012 - 03/2010
4Leukemia
01/2012 - 10/2002
3Obesity
12/2021 - 12/2010
3Colonic Neoplasms (Colon Cancer)
06/2013 - 10/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012 - 05/2006
2Glioma (Gliomas)
01/2020 - 06/2018
2Epilepsy (Aura)
12/2019 - 11/2011
2Autistic Disorder (Autism)
12/2019 - 11/2011
2Intellectual Disability (Idiocy)
12/2019 - 11/2011
2Fibrosis (Cirrhosis)
12/2019 - 05/2004
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2019 - 07/2011
2Liver Neoplasms (Liver Cancer)
01/2018 - 09/2015
2Brain Neoplasms (Brain Tumor)
01/2018 - 03/2006
2Residual Neoplasm
01/2017 - 01/2017
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2016 - 10/2015

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
11CytokinesIBA
12/2021 - 03/2003
10ErbB Receptors (EGF Receptor)IBA
11/2020 - 05/2006
10Phosphotransferases (Kinase)IBA
01/2020 - 06/2006
8Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2002
7Protein Isoforms (Isoforms)IBA
01/2020 - 08/2007
7Pharmaceutical PreparationsIBA
01/2017 - 01/2010
7Sirolimus (Rapamycin)FDA Link
03/2015 - 08/2008
6Retinoblastoma ProteinIBA
12/2019 - 04/2002
5ChromatinIBA
01/2022 - 12/2010
5LipidsIBA
10/2020 - 05/2006
5EnzymesIBA
12/2019 - 03/2006
5Insulin (Novolin)FDA Link
12/2019 - 04/2003
5Oncogene Proteins (Oncogene Protein)IBA
10/2018 - 10/2002
5IntegrinsIBA
01/2018 - 01/2005
5Messenger RNA (mRNA)IBA
01/2018 - 07/2010
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017 - 05/2007
5Mechanistic Target of Rapamycin Complex 1IBA
03/2015 - 08/2008
4trans-sodium crocetinate (crocetin)IBA
01/2021 - 11/2011
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2020 - 04/2014
4Alkylating AgentsIBA
01/2017 - 01/2009
4CollagenIBA
06/2014 - 01/2008
4dactolisibIBA
01/2014 - 11/2009
4Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2009 - 05/2006
3Immunoconjugates (Immunoconjugate)IBA
11/2020 - 01/2017
3Histone DemethylasesIBA
12/2019 - 08/2011
3Cre recombinaseIBA
12/2019 - 08/2007
3Phenobarbital (Luminal)FDA Link
12/2018 - 12/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2018 - 07/2003
3Cyclin D1IBA
01/2017 - 12/2002
3TOR Serine-Threonine KinasesIBA
09/2015 - 01/2010
3LigandsIBA
09/2015 - 10/2002
3CarcinogensIBA
07/2014 - 10/2005
3DNA (Deoxyribonucleic Acid)IBA
02/2014 - 01/2009
3Cholera ToxinIBA
01/2011 - 03/2010
3Small Interfering RNA (siRNA)IBA
11/2009 - 11/2005
2Adenosine Triphosphatases (ATPase)IBA
01/2022 - 01/2020
2Pyruvate KinaseIBA
01/2022 - 01/2016
2CurcuminIBA
12/2021 - 01/2019
2Tuberous Sclerosis Complex 2 ProteinIBA
01/2021 - 12/2019
2Tuberous Sclerosis Complex 1 ProteinIBA
01/2021 - 12/2019
2navitoclaxIBA
11/2020 - 01/2019
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
10/2020 - 04/2014
2Kelch-Like ECH-Associated Protein 1IBA
01/2020 - 11/2017
2AntioxidantsIBA
01/2020 - 01/2004
2NVP-BKM120IBA
01/2020 - 06/2014
2Glucose (Dextrose)FDA LinkGeneric
12/2019 - 01/2016
2E2F Transcription FactorsIBA
12/2019 - 09/2003
2Biological ProductsIBA
11/2019 - 08/2011
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2018 - 06/2011
2Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 03/2013
2Insulin-Like PeptidesIBA
01/2018 - 10/2006
2NFI Transcription FactorsIBA
05/2016 - 07/2011
2Biomarkers (Surrogate Marker)IBA
01/2016 - 12/2010
2Peptides (Polypeptides)IBA
10/2015 - 10/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 08/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 11/2005

Therapy/Procedure

42Therapeutics
11/2020 - 10/2002
3Drug Therapy (Chemotherapy)
11/2020 - 04/2010
3Transplantation
06/2013 - 12/2008
2Immunotherapy
10/2021 - 01/2020
2Punctures
01/2020 - 11/2016
2Ligation
01/2020 - 11/2016
2Ketogenic Diet
01/2019 - 06/2010